Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Omega-3 fatty acids for bipolar disorder
Your Article Summary
See Latest ArticlesImpact of bupropion and cognitive–behavioral treatment for depression on positive affect, negative affect, and urges to smoke during cessation treatment
Nicotine & Tobacco Research, 07/07/09
Strong DR et al. - Results support the efficacy of bupropion in reducing relapse risk associated with urges to smoke and negative affect and suggest the need to better understand the role of low positive affect as a risk factor for early lapse.
Methods- The present report examines affective trajectories and urges to smoke prior to, on quit day, and after quitting in a sample of 524 smokers randomized to receive bupropion versus placebo and CBT versus standard smoking cessation CBT.
- Bupropion and/or CBT did not affect the observed decreases in positive affect and increases in negative affect prior to cessation.
- However, on quit day, observed levels of negative affect and urges to smoke were diminished significantly among individuals receiving bupropion.
- Decreases in positive affect prior to quitting, lower levels of positive affect, and increased levels of negative affect and urges to smoke on quit day were each related to higher risk of smoking lapse.
- Depression proneness was an independent predictor of lower positive affect and higher negative affect but did not moderate the effects of bupropion on outcomes.
- In mediational analyses, the effect of bupropion was accounted for in part by lower negative affect and urges to smoke on quit day.
Related Articles
Review: differences in efficacy and acceptability exist for 12 new-generation antidepressants for major depression
Evidence-Based Medicine, 10/26/09
Relevance Score: 65%
Survival after myocardial infarction worse with first episode major depression than recurrent major depression
Evidence-Based Mental Health, 11/02/09
Relevance Score: 48%
Predictors of depression in a multiethnic cohort of patients with rheumatoid arthritis
Arthritis Care and Research, 11/03/09
Relevance Score: 47%
Quality of life and depression among metastatic breast cancer patients
Medical Oncology, 10/05/09
Relevance Score: 47%
A systematic review of longitudinal studies on the association between depression and smoking in adolescents
BMC Public Health, 10/01/09
Relevance Score: 47%
Today in Mood Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
Ethnic differences in antidepressant response: a prospective multi site clinical trial
Depression and Anxiety, 12/09/09
Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals
Journal of Affective Disorders, 12/09/09
Is pregnancy associated with mood and anxiety disorders? A cross-sectional study
General Hospital Psychiatry, 12/09/09
Today in Neuro/Psych Pharmacol...keeping you current
Receive free subspecialty "5-minute updates" via email
Update on the management of attention-deficit/hyperactivity disorder in children and adults: patient onsiderations and the role of lisdexamfetamine
Therapeutics and Clinical Risk Management, 12/09/09
A Preliminary Controlled Trial of Cognitive Behavioral Therapy in Clozapine-Resistant Schizophrenia
The Journal of Nervous and Mental Disease, 12/09/09
Psychophysiological disorders among buprenorphine patients
International Journal of Psychiatry in Clinical Practice, 12/09/09
Today in Psychotherapy/analysis...keeping you current
Receive free subspecialty "5-minute updates" via email
A Preliminary Controlled Trial of Cognitive Behavioral Therapy in Clozapine-Resistant Schizophrenia
The Journal of Nervous and Mental Disease, 12/09/09
Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder
Expert Opinion in Pharmacotherapy, 12/09/09
Combination of intensive cognitive rehabilitation and donepezil therapy in Alzheimer's disease (AD)
Archives of Gerontology and Geriatrics, 12/09/09
Today in Substance Abuse...keeping you current
Receive free subspecialty "5-minute updates" via email
A controlled trial of flumazenil and gabapentin for initial treatment of methylamphetamine dependence
Journal of Psychopharmacology, 12/09/09
Psychophysiological disorders among buprenorphine patients
International Journal of Psychiatry in Clinical Practice, 12/09/09
High-potency cannabis and the risk of psychosis
British Journal of Psychiatry, 12/09/09
Sponsor
Article Search
Sponsor